VAERS reports by lot

Merck Pneumococcal lot N022303: VAERS reports

61 VAERS reports list lot N022303 as a Merck Pneumococcal vaccine, received between 2017-10-19 and 2019-11-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
61
Reports
15%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction7937%
General / Systemic (non-local)2914%
Allergic / Anaphylactic2210%
Musculoskeletal188%
Dermatological (non-injection-site)188%
Cardiac / Cardiovascular178%
Neurological136%
Gastrointestinal115%
Respiratory52%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Ohio10
New York6
Pennsylvania6
North Carolina4
Texas4
South Carolina3
Missouri3
Florida2
California2
Tennessee2
Georgia2
Michigan1

Reports by month received

2017-105
2017-1113
2017-128
2018-015
2018-027
2018-033
2018-043
2018-053
2018-071
2018-084
2018-092
2018-102
2018-112
2018-121
2019-011
2019-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.